Commission approval of final consent order: Following a public comment period, the Commission has approved a final consent order in the matter concerning Genzyme Corporation and ILEX Oncology, Inc. The Commission vote approving the final consent order was 4-0-1, with Commissioner Pamela Jones Harbour recused. (FTC File No. 041-0083; the staff contact is Paul R. Frontczak, Bureau of Competition, 202-326-3002; see press release dated December 20, 2004.)
Copies of the documents mentioned in this release are available from the FTC’s Web site at http://www.ftc.gov and also from the FTC’s Consumer Response Center, Room 130, 600 Pennsylvania Avenue, N.W., Washington, DC 20580. Call toll-free: 1-877-FTC-HELP.